These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15827015)

  • 1. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
    Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
    Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
    Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
    Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
    Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
    Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling drug modulation of nystagmus.
    Glasauer S; Rössert C
    Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
    Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
    Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
    Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
    Sprenger A; Rambold H; Sander T; Marti S; Weber K; Straumann D; Helmchen C
    Neurology; 2006 Sep; 67(5):905-7. PubMed ID: 16966567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
    Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
    J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
    Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
    J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth pursuit in patients with downbeat nystagmus.
    Glasauer S; Hoshi M; Büttner U
    Ann N Y Acad Sci; 2005 Apr; 1039():532-5. PubMed ID: 15827016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
    Glasauer S; Rössert C; Strupp M
    Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upbeat nystagmus changes to downbeat nystagmus with upward gaze in a patient with Wernicke's encephalopathy.
    Shin BS; Oh SY; Kim JS; Lee H; Kim EJ; Hwang SB
    J Neurol Sci; 2010 Nov; 298(1-2):145-7. PubMed ID: 20832081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertical nystagmus: clinical facts and hypotheses.
    Pierrot-Deseilligny C; Milea D
    Brain; 2005 Jun; 128(Pt 6):1237-46. PubMed ID: 15872015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged asymmetric smooth-pursuit stimulation leads to downbeat nystagmus in healthy human subjects.
    Marti S; Bockisch CJ; Straumann D
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):143-9. PubMed ID: 15623767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.
    Feil K; Claaßen J; Bardins S; Teufel J; Habs M; Kalla R; Strupp M
    J Neurol; 2013 May; 260(5):1426-8. PubMed ID: 23595790
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
    Kalla R; Teufel J; Feil K; Muth C; Strupp M
    J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
    Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
    J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
    Claassen J; Spiegel R; Kalla R; Faldon M; Kennard C; Danchaivijitr C; Bardins S; Rettinger N; Schneider E; Brandt T; Jahn K; Teufel J; Strupp M; Bronstein A
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1392-9. PubMed ID: 23813743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.
    Hüfner K; Stephan T; Kalla R; Deutschländer A; Wagner J; Holtmannspötter M; Schulte-Altedorneburg G; Strupp M; Brandt T; Glasauer S
    Neurology; 2007 Sep; 69(11):1128-35. PubMed ID: 17846412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of upbeat to downbeat nystagmus in Wernicke encephalopathy.
    Kattah JC; Tehrani AS; du Lac S; Newman-Toker DE; Zee DS
    Neurology; 2018 Oct; 91(17):790-796. PubMed ID: 30348852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.